Name: #541: Taiwan Town Hall: Strategies to Promote Medicine Supply Resilience
Start: 2026-06-16T13:45:00-0400
End: 2026-06-16T15:00:00-0400

#541: Taiwan Town Hall: Strategies to Promote Medicine Supply Resilience

Tuesday June 16, 2026 1:45pm - 3:00pm EDT

112AB

Component Type: Session
Level: Intermediate
CE: ACPE 1.25 Knowledge UAN: 0286-0000-26-669-L04-P; CME 1.25; RN 1.25

This Taiwan Town Hall showcases Taiwan’s evolving approach to medicine supply resilience. It brings together regulators, industry, and health systems from Taiwan, the EU, Japan, and the US to explore coordinated global pathways for critical medicines.

Learning Objectives

Explain Taiwan’s transition from medicine shortage management to supply resilience governance; Compare regulator, industry, and health system perspectives from Taiwan, EU, Japan, and US on critical medicines and international cooperation; Identify practical pathways for Taiwan to engage with global partners to strengthen coordinated frameworks for resilient medicine supply.

Chair

Chih-Kang Chiang, MD

Speaker

From Shortage Management to Resilience Governance: Taiwan’s Evolving Policy Approach
Chih-Kang Chiang, MD

From Regulation to Resilience: Taiwan’s Strategy in Controlled Drug Manufacturing and Future Directions
Meng-Hsiu Wu

From Shortage to Resilience: Building Medication Supply Preparedness in Health Systems
Matthew Eberts, PHARMD, MBA, MHA

Lessons from Japan: Rebuilding Domestic Antibiotics Production for Enhanced Supply Resilience
Masaya Tamae

Speakers

Chih-Kang Chiang

Director General, Taiwan Food and Drug Administration, Taiwan

Dr. Chiang has been the Director General of Taiwan Food and Drug Administration (TFDA) since February 27, 2025. He oversees the regulation of food, drugs, medical devices, and cosmetics. Prior to the DG of TFDA, Dr. Chiang was a highly accomplished professional serving as the Director... Read More →

Matt Eberts

Senior Director System Pharmacy Business and Outcomes, University of Maryland Medical System, United States

Matt is the Senior Director of System Pharmacy Business and Outcomes for the University of Maryland Medical System (UMMS). In his role he is responsible for the medication supply chain, centralized distribution, and business functions for the 12 hospital health care system.